Details for Patent: 9,649,364
✉ Email this page to a colleague
Which drugs does patent 9,649,364 protect, and when does it expire?
Patent 9,649,364 protects GVOKE HYPOPEN and GVOKE PFS and is included in one NDA.
This patent has twenty-one patent family members in fourteen countries.
Summary for Patent: 9,649,364
Title: | Methods for producing stable therapeutic formulations in aprotic polar solvents |
Abstract: | Certain embodiments are directed to a formulation of a therapeutic agent, as well as a method of making such a formulation, comprising at least one therapeutic agent dissolved in an aprotic polar solvent system comprising at least one ionization stabilizing excipient in a concentration sufficient to impart physical and chemical stability to the therapeutic agent. |
Inventor(s): | Prestrelski; Steven (San Diego, CA), Sandoval; Michael (Austin, TX), Donovan; Martin (Austin, TX) |
Assignee: | XERIS PHARMACEUTICALS, INC. (Austin, TX) |
Application Number: | 15/136,650 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Compound; |
Drugs Protected by US Patent 9,649,364
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Xeris | GVOKE HYPOPEN | glucagon | SOLUTION;SUBCUTANEOUS | 212097-003 | Sep 10, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF SEVERE HYPOGLYCEMIA | ⤷ Sign Up | |||
Xeris | GVOKE HYPOPEN | glucagon | SOLUTION;SUBCUTANEOUS | 212097-004 | Sep 10, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF SEVERE HYPOGLYCEMIA | ⤷ Sign Up | |||
Xeris | GVOKE PFS | glucagon | SOLUTION;SUBCUTANEOUS | 212097-001 | Sep 10, 2019 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF SEVERE HYPOGLYCEMIA | ⤷ Sign Up | |||
Xeris | GVOKE PFS | glucagon | SOLUTION;SUBCUTANEOUS | 212097-002 | Sep 10, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF SEVERE HYPOGLYCEMIA | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,649,364
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2016326749 | ⤷ Sign Up | |||
Brazil | 112018005800 | ⤷ Sign Up | |||
Canada | 2999404 | ⤷ Sign Up | |||
Canada | 3204984 | ⤷ Sign Up | |||
China | 108135980 | ⤷ Sign Up | |||
China | 115531523 | ⤷ Sign Up | |||
Eurasian Patent Organization | 201890704 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |